HWM
UTHR icon

Hohimer Wealth Management’s United Therapeutics UTHR Stock Holding History

Hohimer Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,325
Closed -$5.52M – 420
2025
Q4 		$5.52M Sell
11,325
-45
-0.4% -$21K 0.74% 33
2025
Q3 		$4.77M Sell
11,370
-1,256
-10% -$422K 0.67% 37
2025
Q2 		$3.63M Sell
12,626
-25
-0.2% -$7.47K 0.64% 54
2025
Q1 		$3.9M Buy
12,651
+37
+0.3% +$12.7K 0.76% 45
2024
Q4 		$4.45M Buy
12,614
+40
+0.3% +$14.7K 0.84% 34
2024
Q3 		$4.51M Sell
12,574
-9
-0.1% -$3.04K 0.97% 30
2024
Q2 		$4.01M Buy
+12,583
New +$3.33M 0.93% 31

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Hohimer Wealth Management's UTHR Position: Q1 2026 in Review

Hohimer Wealth Management sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 11,325 shares — an estimated $5.52M sold.

Hohimer Wealth Management first reported a position in UTHR in Q2 2024 and held it in 7 quarters. The position peaked at $5.52M in Q4 2025. 854 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Hohimer Wealth Management reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Hohimer Wealth Management sold 11,325 United Therapeutics shares in Q1 2026, an estimated $5.52M.
  • Hohimer Wealth Management first reported a position in United Therapeutics in Q2 2024 and held it in 7 quarters.
  • Hohimer Wealth Management's United Therapeutics position peaked at $5.52M in Q4 2025.
  • 854 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Hohimer Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.